Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression
- PMID: 19150053
- PMCID: PMC2680424
- DOI: 10.1016/j.biopsych.2008.11.029
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression
Abstract
Recognition that inflammation may represent a common mechanism of disease has been extended to include neuropsychiatric disorders including major depression. Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomarkers, including inflammatory cytokines, which have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter metabolism, neuroendocrine function, and neural plasticity. Indeed, activation of inflammatory pathways within the brain is believed to contribute to a confluence of decreased neurotrophic support and altered glutamate release/reuptake, as well as oxidative stress, leading to excitotoxicity and loss of glial elements, consistent with neuropathologic findings that characterize depressive disorders. Further instantiating the link between inflammation and depression are data demonstrating that psychosocial stress, a well-known precipitant of mood disorders, is capable of stimulating inflammatory signaling molecules, including nuclear factor kappa B, in part, through activation of sympathetic nervous system outflow pathways. Interestingly, depressed patients with increased inflammatory biomarkers have been found to be more likely to exhibit treatment resistance, and in several studies, antidepressant therapy has been associated with decreased inflammatory responses. Finally, preliminary data from patients with inflammatory disorders, as well as medically healthy depressed patients, suggest that inhibiting proinflammatory cytokines or their signaling pathways may improve depressed mood and increase treatment response to conventional antidepressant medication. Translational implications of these findings include the unique opportunity to identify relevant patient populations, apply immune-targeted therapies, and monitor therapeutic efficacy at the level of the immune system in addition to behavior.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2680424/bin/nihms-106144-f0001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2680424/bin/nihms-106144-f0002.gif)
Similar articles
-
Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110343. doi: 10.1016/j.pnpbp.2021.110343. Epub 2021 May 5. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33961966 Review.
-
Inflammation in psychiatric disorders: what comes first?Ann N Y Acad Sci. 2019 Feb;1437(1):57-67. doi: 10.1111/nyas.13712. Epub 2018 May 11. Ann N Y Acad Sci. 2019. PMID: 29752710 Review.
-
Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.Mol Psychiatry. 2016 Oct;21(10):1351-7. doi: 10.1038/mp.2015.206. Epub 2016 Jan 12. Mol Psychiatry. 2016. PMID: 26754953 Free PMC article.
-
Is depression an inflammatory disorder?Curr Psychiatry Rep. 2011 Dec;13(6):467-75. doi: 10.1007/s11920-011-0232-0. Curr Psychiatry Rep. 2011. PMID: 21927805 Free PMC article. Review.
-
Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.Arch Gen Psychiatry. 2010 Dec;67(12):1211-24. doi: 10.1001/archgenpsychiatry.2010.161. Arch Gen Psychiatry. 2010. PMID: 21135322 Free PMC article. Review.
Cited by
-
The moderating effect of physical activity on the relationship between neutrophil count and depressive symptoms.Sci Rep. 2024 Jun 2;14(1):12647. doi: 10.1038/s41598-024-63432-x. Sci Rep. 2024. PMID: 38825659 Free PMC article.
-
Effective factors in the pathogenesis of Toxoplasmagondii.Heliyon. 2024 May 19;10(10):e31558. doi: 10.1016/j.heliyon.2024.e31558. eCollection 2024 May 30. Heliyon. 2024. PMID: 38818168 Free PMC article. Review.
-
Chronic Stress-Induced Neuroinflammation: Relevance of Rodent Models to Human Disease.Int J Mol Sci. 2024 May 7;25(10):5085. doi: 10.3390/ijms25105085. Int J Mol Sci. 2024. PMID: 38791125 Free PMC article. Review.
-
The Emerging Role of Human Gut Bacteria Extracellular Vesicles in Mental Disorders and Developing New Pharmaceuticals.Curr Issues Mol Biol. 2024 May 15;46(5):4751-4767. doi: 10.3390/cimb46050286. Curr Issues Mol Biol. 2024. PMID: 38785554 Free PMC article. Review.
-
Exploring the Psychiatric Manifestations of Primary Sjögren's Syndrome: A Narrative Review.Int J Rheumatol. 2024 May 14;2024:5520927. doi: 10.1155/2024/5520927. eCollection 2024. Int J Rheumatol. 2024. PMID: 38774059 Free PMC article. Review.
References
-
- Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet. 2007;370:851–858. - PubMed
-
- Rush AJ. STAR*D: What have we learned. Am J Psychiatry. 2007;164:739–752. - PubMed
-
- Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: How hot is the link? Biochem Pharmacol. 2006;72:1605–1621. - PubMed
-
- Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: Implications for longevity. Nutr Rev. 2007;65:S253–259. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR00039/RR/NCRR NIH HHS/United States
- K23 MH064619/MH/NIMH NIH HHS/United States
- R01 MH083746/MH/NIMH NIH HHS/United States
- R01 MH070553/MH/NIMH NIH HHS/United States
- M01 RR000039/RR/NCRR NIH HHS/United States
- T32 MH020018/MH/NIMH NIH HHS/United States
- K05 MH069124/MH/NIMH NIH HHS/United States
- K05 MH069124-01/MH/NIMH NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- R01 HL073921-01A1/HL/NHLBI NIH HHS/United States
- R01 MH070553-02/MH/NIMH NIH HHS/United States
- R01 HL073921/HL/NHLBI NIH HHS/United States
- K23 MH064619-01/MH/NIMH NIH HHS/United States
- T32 MH020018-05/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical